Log In
Print
BCIQ
Print
Print this Print this
 

Anti-IL-6R (ALX-0061)

  Manage Alerts
Collapse Summary General Information
Company Ablynx N.V.
DescriptionNanobody against IL-6 receptor (CD126)
Molecular Target Interleukin-6 (IL-6) receptor (CD126)
Mechanism of ActionInterleukin-6 (IL-6) receptor (CD126) inhibitor
Latest Stage of DevelopmentPhase II
IndicationRheumatoid arthritis (RA)
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today